These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 9196138)
1. Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults. Bow EJ; Loewen R; Cheang MS; Shore TB; Rubinger M; Schacter B J Clin Oncol; 1997 Jun; 15(6):2254-61. PubMed ID: 9196138 [TBL] [Abstract][Full Text] [Related]
2. Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia. Bow EJ; Meddings JB Leukemia; 2006 Dec; 20(12):2087-92. PubMed ID: 17082779 [TBL] [Abstract][Full Text] [Related]
3. Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Bow EJ; Loewen R; Cheang MS; Schacter B Clin Infect Dis; 1995 Aug; 21(2):361-9. PubMed ID: 8562745 [TBL] [Abstract][Full Text] [Related]
4. Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer? Dagdemir A; Yildirim H; Aliyazicioglu Y; Kanber Y; Albayrak D; Acar S Support Care Cancer; 2004 Apr; 12(4):263-7. PubMed ID: 14767751 [TBL] [Abstract][Full Text] [Related]
5. Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin. Bow EJ; Gallant G; Williams GJ; Woloschuk D; Shore TB; Rubinger M; Schacter BA Cancer; 1998 Oct; 83(7):1344-54. PubMed ID: 9762935 [TBL] [Abstract][Full Text] [Related]
6. Impact of the D-index deduced from duration and intensity of neutropenia following chemotherapy on the risk of invasive fungal infection in pediatric acute myeloid leukemia. Sano H; Kobayashi R; Suzuki D; Hori D; Kishimoto K; Kobayashi K Int J Hematol; 2018 Jul; 108(1):85-90. PubMed ID: 29564800 [TBL] [Abstract][Full Text] [Related]
7. Use of kinetic methods to evaluate D-xylose malabsorption in patients. Breiter HC; Craig RM; Levee G; Atkinson AJ J Lab Clin Med; 1988 Nov; 112(5):533-43. PubMed ID: 3183487 [TBL] [Abstract][Full Text] [Related]
8. Nutrition and acute leukemia in adults: relation between nutritional status and infectious complications during remission induction. Eriksson KM; Cederholm T; Palmblad JE Cancer; 1998 Mar; 82(6):1071-7. PubMed ID: 9506351 [TBL] [Abstract][Full Text] [Related]
10. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve. Portugal RD; Garnica M; Nucci M J Clin Oncol; 2009 Aug; 27(23):3849-54. PubMed ID: 19597026 [TBL] [Abstract][Full Text] [Related]
11. Small intestinal malabsorption in chronic alcoholism: a retrospective study of alcoholic patients by the ¹⁴C-D-xylose breath test. Hope H; Skar V; Sandstad O; Husebye E; Medhus AW Scand J Gastroenterol; 2012 Apr; 47(4):428-34. PubMed ID: 22229732 [TBL] [Abstract][Full Text] [Related]
12. Improving the serum D-xylose test for the identification of patients with small intestinal malabsorption. Ehrenpreis ED; Salvino M; Craig RM J Clin Gastroenterol; 2001 Jul; 33(1):36-40. PubMed ID: 11418788 [TBL] [Abstract][Full Text] [Related]
13. [Disorders of intestinal absorption in patients treated with cytostatic chemotherapy]. Hürter T; Reis HE; Borchard F Z Gastroenterol; 1989 Oct; 27(10):606-10. PubMed ID: 2588735 [TBL] [Abstract][Full Text] [Related]
14. D-xylose hydrogen breath tests compared to absorption kinetics in human patients with and without malabsorption. Carlson S; Craig RM Dig Dis Sci; 1995 Oct; 40(10):2259-67. PubMed ID: 7587799 [TBL] [Abstract][Full Text] [Related]
15. Labeled acetate to assess intestinal absorption in critically ill patients. Chioléro RL; Revelly JP; Berger MM; Cayeux MC; Schneiter P; Tappy L Crit Care Med; 2003 Mar; 31(3):853-7. PubMed ID: 12626996 [TBL] [Abstract][Full Text] [Related]
16. Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. Wiley JM; Smith N; Leventhal BG; Graham ML; Strauss LC; Hurwitz CA; Modlin J; Mellits D; Baumgardner R; Corden BJ J Clin Oncol; 1990 Feb; 8(2):280-6. PubMed ID: 2299371 [TBL] [Abstract][Full Text] [Related]
17. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole. Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251 [TBL] [Abstract][Full Text] [Related]